{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:43:58Z","timestamp":1649144638785},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00108-018-0459-5","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T08:04:40Z","timestamp":1530777880000},"page":"981-992","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Persistierendes Foramen ovale \u2013 Intervention oder Arzneitherapie"],"prefix":"10.1007","volume":"59","author":[{"given":"C.","family":"Liebetrau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. W.","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,5]]},"reference":[{"issue":"3","key":"459_CR1","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s00415-018-8750-x","volume":"265","author":"E Abo-Salem","year":"2018","unstructured":"Abo-Salem E, Chaitman B, Helmy T, Boakye EA, Alkhawam H, Lim M (2018) Patent foramen ovale closure versus medical therapy in cases with cryptogenic stroke, meta-analysis of randomized controlled trials. J\u00a0Neurol 265(3):578\u2013585","journal-title":"J Neurol"},{"issue":"12","key":"459_CR2","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","volume":"368","author":"JD Carroll","year":"2013","unstructured":"Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL, RESPECT Investigators (2013) Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N\u00a0Engl J Med 368(12):1092\u20131100","journal-title":"N Engl J Med"},{"issue":"5","key":"459_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.7326\/M17-3033","volume":"168","author":"S Rosa De","year":"2018","unstructured":"De Rosa S, Sievert H, Sabatino J, Polimeni A, Sorrentino S, Indolfi C (2018) Percutaneous closure versus medical treatment in stroke patients with patent foramen ovale: a systematic review and meta-analysis. Ann Intern Med 168(5):343\u2013350","journal-title":"Ann Intern Med"},{"issue":"11","key":"459_CR4","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1009639","volume":"366","author":"AJ Furlan","year":"2012","unstructured":"Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A, Wechsler L, CLOSURE I Investigators (2012) Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N\u00a0Engl J Med 366(11):991\u2013999","journal-title":"N Engl J Med"},{"issue":"8","key":"459_CR5","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jacc.2015.12.023","volume":"67","author":"DM Kent","year":"2016","unstructured":"Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, Saver JL, Smalling RW, J\u00fcni P, Mattle HP, Meier B, Thaler DE (2016) Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials. J\u00a0Am Coll Cardiol 67(8):907\u2013917","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"459_CR6","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJM198805053181802","volume":"318","author":"P Lechat","year":"1988","unstructured":"Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, Dobrinski G, Thomas D, Grosgogeat Y (1988) Prevalence of patent foramen ovale in patients with stroke. N\u00a0Engl J Med 318(18):1148\u20131152","journal-title":"N Engl J Med"},{"key":"459_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.02.046","author":"PH Lee","year":"2018","unstructured":"Lee PH, Song JK, Kim JS, Heo R, Lee S, Kim DH, Song JM, Kang DH, Kwon SU, Kang DW, Lee D, Kwon HS, Yun SC, Sun BJ, Park JH, Lee JH, Jeong HS, Song HS, Kim J, Park JS (2018) Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial. J\u00a0Am Coll Cardiol. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2018.02.046","journal-title":"J Am Coll Cardiol"},{"key":"459_CR8","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1056\/NEJMoa011503","volume":"345","author":"JL Mas","year":"2001","unstructured":"Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J (2001) Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N\u00a0Engl J Med 345:1740\u20131746","journal-title":"N Engl J Med"},{"issue":"11","key":"459_CR9","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","volume":"377","author":"J-L Mas","year":"2017","unstructured":"Mas J\u2011L, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, Arquizan C, B\u00e9jot Y, Vuillier F, Detante O, Guidoux C, Canaple S, Vaduva C, Dequatre-Ponchelle N, Sibon I, Garnier P, Ferrier A, Timsit S, Robinet-Borgomano E, Sablot D, Lacour JC, Zuber M, Favrole P, Pinel JF, Apoil M, Reiner P, Lefebvre C, Gu\u00e9rin P, Piot C, Rossi R, Dubois-Rand\u00e9 JL, Eicher JC, Meneveau N, Lusson JR, Bertrand B, Schleich JM, Godart F, Thambo JB, Leborgne L, Michel P, Pierard L, Turc G, Barthelet M, Charles-Nelson A, Weimar C, Moulin T, Juliard JM, Chatellier G, CLOSE Investigators (2017) Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N\u00a0Engl J Med 377(11):1011\u20131021","journal-title":"N Engl J Med"},{"issue":"12","key":"459_CR10","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","volume":"368","author":"B Meier","year":"2013","unstructured":"Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, Ibrahim R, Schuler G, Walton AS, Wahl A, Windecker S, J\u00fcni P, PC Trial Investigators (2013) Percutaneous closure of patent foramen ovale in cryptogenic embolism. N\u00a0Engl J Med 368(12):1083\u20131091","journal-title":"N Engl J Med"},{"key":"459_CR11","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1056\/NEJMoa011258","volume":"345","author":"JP Mohr","year":"2001","unstructured":"Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP Jr, Jackson CM, Pullicino P, Warfarin-Aspirin Recurrent Stroke Study Group (2001) A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N\u00a0Engl J Med 345:1444\u20131451","journal-title":"N Engl J Med"},{"issue":"2","key":"459_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1161\/STROKEAHA.117.020030","volume":"49","author":"G Ntaios","year":"2018","unstructured":"Ntaios G, Papavasileiou V, Sagris D, Makaritsis K, Vemmos K, Steiner T, Michel P (2018) Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: updated systematic review and meta-analysis. Stroke 49(2):412\u2013418","journal-title":"Stroke"},{"key":"459_CR13","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1212\/WNL.55.8.1172","volume":"55","author":"JR Overell","year":"2000","unstructured":"Overell JR, Bone I, Lees KR (2000) Interatrial septal abnormalities and stroke: a\u00a0meta-analysis of case-control studies. Neurology 55:1172\u20131179","journal-title":"Neurology"},{"key":"459_CR14","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1161\/CIRCULATIONAHA.109.192272","volume":"119","author":"PT O\u2019Gara","year":"2009","unstructured":"O\u2019Gara PT, Messe SR, Tuzcu EM, Catha G, Ring JC (2009) Percutaneous device closure of patent foramen ovale for secondary prevention. A Call for completion of randomized clinical trials. Circulation 119:2743\u20132747 (A Science Advisory From the American Heart Association\/American Stroke Association and the American College of Cardiology Foundation)","journal-title":"Circulation"},{"issue":"1","key":"459_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ccd.24693","volume":"82","author":"C Pristipino","year":"2013","unstructured":"Pristipino C, Anzola GP, Ballerini L, Bartorelli A, Cecconi M, Chessa M, Donti A, Gaspardone A, Neri G, Onorato E, Palareti G, Rakar S, Rigatelli G, Santoro G, Toni D, Ussia GP, Violini R (2013) Management of patients with patent foramen ovale and cryptogenic stroke: a collaborative, multidisciplinary, position paper: executive summary. Catheter Cardiovasc Interv 82(1):122\u2013129","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"459_CR16","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1056\/NEJMcp1503946","volume":"374","author":"JL Saver","year":"2016","unstructured":"Saver JL (2016) Clinical practice. Cryptogenic stroke. N\u00a0Engl J Med 374:2065\u20132074","journal-title":"N Engl J Med"},{"issue":"11","key":"459_CR17","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","volume":"377","author":"JL Saver","year":"2017","unstructured":"Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL, RESPECT Investigators (2017) Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N\u00a0Engl J Med 377(11):1022\u20131032","journal-title":"N Engl J Med"},{"issue":"5","key":"459_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.7326\/M17-2679","volume":"168","author":"R Shah","year":"2018","unstructured":"Shah R, Nayyar M, Jovin IS, Rashid A, Bondy BR, Fan TM, Flaherty MP, Rao SV (2018) Device closure versus medical therapy alone for patent foramen ovale in patients with cryptogenic stroke: a systematic review and meta-analysis. Ann Intern Med 168(5):335\u2013342","journal-title":"Ann Intern Med"},{"issue":"11","key":"459_CR19","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","volume":"377","author":"L S\u00f8ndergaard","year":"2017","unstructured":"S\u00f8ndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, Settergren M, Sj\u00f6strand C, Roine RO, Hildick-Smith D, Spence JD, Thomassen L, Gore REDUCE Clinical Study Investigators (2017) Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N\u00a0Engl J Med 377(11):1033\u20131042","journal-title":"N Engl J Med"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-018-0459-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-018-0459-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-018-0459-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T19:22:09Z","timestamp":1562268129000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-018-0459-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,5]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["459"],"URL":"https:\/\/doi.org\/10.1007\/s00108-018-0459-5","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,5]]},"assertion":[{"value":"5 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Liebetrau und C.W.\u00a0Hamm geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}